Sergio Mecarocci

614 total citations
22 papers, 432 citations indexed

About

Sergio Mecarocci is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Sergio Mecarocci has authored 22 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Sergio Mecarocci's work include Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Sergio Mecarocci is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Sergio Mecarocci collaborates with scholars based in Italy and United States. Sergio Mecarocci's co-authors include Maria Concetta Petti, Claudio Cartoni, Francesco Dragoni, F Mandelli, Alessandra Micozzi, Edoardo Pescarmona, Piero Chirletti, Giovanna Meloni, Massimo Breccia and Giuliana Alimena and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sergio Mecarocci

19 papers receiving 420 citations

Peers

Sergio Mecarocci
Omar Racchi Italy
NKC Ramsay United States
Sophie Lechaton France
Qilong Yi United States
Uğur Şahin Türkiye
Jolanta Goździk Poland
Lisa Brennan United States
Ted Gooley United States
Angélique Rome France
Paul J. Petruska United States
Omar Racchi Italy
Sergio Mecarocci
Citations per year, relative to Sergio Mecarocci Sergio Mecarocci (= 1×) peers Omar Racchi

Countries citing papers authored by Sergio Mecarocci

Since Specialization
Citations

This map shows the geographic impact of Sergio Mecarocci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Mecarocci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Mecarocci more than expected).

Fields of papers citing papers by Sergio Mecarocci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Mecarocci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Mecarocci. The network helps show where Sergio Mecarocci may publish in the future.

Co-authorship network of co-authors of Sergio Mecarocci

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Mecarocci. A scholar is included among the top collaborators of Sergio Mecarocci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Mecarocci. Sergio Mecarocci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Bagni, Oreste, Sergio Mecarocci, Elettra Ortu La Barbera, et al.. (2018). Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin’s lymphoma. Leukemia Research. 76. 48–52. 6 indexed citations
5.
Annibali, Ombretta, Francesca Chiodi, Chiara Sarlo, et al.. (2015). R-COMP Regimen in B Cell Non Hodgkin Lymphoma Patients with Cardiovascular Comorbidities. Blood. 126(23). 5096–5096.
6.
Marchesi, Francesco, Maria Laura Dessanti, Sergio Mecarocci, et al.. (2013). A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment. Journal of Geriatric Oncology. 4(3). 242–248. 30 indexed citations
7.
Pessina, G, Sergio Mecarocci, Angela Rago, et al.. (2013). A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms. Annals of Hematology. 93(4). 609–616. 4 indexed citations
8.
Rago, Angela, Sara Grammatico, Tommaso Zà, et al.. (2012). Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form. Cancer. 118(22). 5544–5549. 9 indexed citations
9.
Elia, Loredana, Sara Grammatico, Francesca Paoloni, et al.. (2011). Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene. American Journal of Hematology. 86(12). 993–997. 5 indexed citations
10.
Girmenia, Corrado, Eleonora Russo, Ida Carmosino, et al.. (2007). Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Annals of Hematology. 86(4). 263–270. 16 indexed citations
11.
Breccia, Massimo, Laura Cannella, Daniela Diverio, et al.. (2007). Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib. Leukemia Research. 32(1). 177–180. 11 indexed citations
12.
Latagliata, Roberto, Velia Bongarzoni, Ida Carmosino, et al.. (2005). Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon. Annals of Oncology. 17(2). 281–285. 30 indexed citations
13.
Breccia, Massimo, et al.. (2004). Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib.. PubMed. 89(4). ECR11–ECR11. 8 indexed citations
14.
Breccia, Massimo, Maria Concetta Petti, Emanuela Ottaviani, et al.. (2002). Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI‐1‐positive, 3q21q26 syndrome and T cell‐line antigen expression: what is the EVI‐1 gene role?. British Journal of Haematology. 118(2). 438–441. 15 indexed citations
15.
Breccia, Massimo, Corrado Girmenia, Sergio Mecarocci, et al.. (2001). Ogilvie's syndrome in acute myeloid leukemia: pharmacological approach with neostigmine. Annals of Hematology. 80(10). 614–616. 12 indexed citations
16.
Cartoni, Claudio, Francesco Dragoni, Alessandra Micozzi, et al.. (2001). Neutropenic Enterocolitis in Patients With Acute Leukemia: Prognostic Significance of Bowel Wall Thickening Detected by Ultrasonography. Journal of Clinical Oncology. 19(3). 756–761. 134 indexed citations
17.
Muscaritoli, Maurizio, et al.. (1999). Plasma amino acid concentrations in patients with acute myelogenous leukemia. Nutrition. 15(3). 195–199. 22 indexed citations
18.
Marignani, Massimo, Sergio Mecarocci, Cesare Bordi, et al.. (1999). High Prevalence of Atrophic Body Gastritis in Patients With Unexplained Microcytic and Macrocytic Anemia. The American Journal of Gastroenterology. 94(3). 766–772. 67 indexed citations
19.
Avvisati, Giuseppe, et al.. (1996). Simultaneous Occurrence of Large B-Cell non-Hodgkin Lymphoma and Myelodysplastic Syndrome Rapidly Evolving into Acute Myeloblastic Leukemia. Leukemia & lymphoma. 21(3-4). 339–341. 5 indexed citations
20.
Pulsoni, Alessandro, Paolo Bianco, Giacinto La Verde, et al.. (1993). Coexistent Multiple Myeloma and Myelofibrosis. Leukemia & lymphoma. 10(4-5). 401–403. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Racchi Breakdown of academic impact, for papers by NKC Ramsay Breakdown of academic impact, for papers by Sophie Lechaton Breakdown of academic impact, for papers by Qilong Yi Breakdown of academic impact, for papers by Uğur Şahin Breakdown of academic impact, for papers by Jolanta Goździk Breakdown of academic impact, for papers by Lisa Brennan Breakdown of academic impact, for papers by Ted Gooley Breakdown of academic impact, for papers by Angélique Rome Breakdown of academic impact, for papers by Paul J. Petruska
Rankless by CCL
2026